期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

二磷酸盐在防治股骨头坏死中的研究现状 被引量：3

原文传递
导出
摘要 股骨头坏死（osteonecrosisofthefemoralhead，ONFH）是由不同病因引起的股骨头血液供应破坏或骨细胞变性导致骨细胞、骨髓细胞等凋亡、坏死引起的病理过程。该病常见诱因有激素、酗酒、创伤、凝血障碍和血管解剖畸形。
作者 谢小伟 谭振 裴福兴 康鹏德
机构地区 四川大学华西医院骨科
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2013年第9期893-896,共4页 Orthopedic Journal of China
基金 国家自然科学基金面上项目资助(项目编号:81271976/H0605 81171763和30772202/C1607)
关键词 二磷酸盐 股骨头坏死
分类号 R681.8 [医药卫生—骨科学]
  • 相关文献

参考文献30

  • 1Mont MA, Zywiel MG, Marker DR,et al. The natural history of un- treated asymptomatic osteonecrosis of the femoral head : a systematic literature review [ J ]. J Bone Joint Surg Am,2010,12:2165 - 2170.
  • 2Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyap- atite dissolution in vitro and bone resorption in tissue culture and in vivo [ J ]. Science, 1969,3899 : 1262 - 1264.
  • 3Russell RG. Bisphosphonates : the first 40 years [ J ]. Bone,2011,1 : 2 -19.
  • 4Soe K, Delaiss6 JM. Glucocorticoids maintain human osteoclasts in the active mode of their resorption cycle [ J ]. J Bone Miner Res, 2010,10:2184 - 2192.
  • 5Rogers M J, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of bisphosphonates [ J ]. Cancer,2000,12:2961 - 2978.
  • 6Rogers M J, Crockett JC, Coxon FP, et al. Biochemical and molecu- lar mechanisms of action of bisphosphonates[ J. Bone, 2011,1:34 -41.
  • 7Ohe JY, Kwon YD, Lee HW. Bisphosphonates modulate the expres-sion of OPG and M - CSF in hMSC - derived osteoblasts [ J ]. Clin O- ral Investig,2012,4 : 1153 - 1159.
  • 8Tsubaki M, Satan T, Itoh T, et al. Bisphosphonate - and statin - in- duced enhancement of OPG expression and inhibition of CD9, M - CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2 [ J]. Mol Cell Endocrinol,2012,1 -2:219 -231.
  • 9Sakai H, Chen Y, Itokawa T. Activated c - Fms recruits Vav and Rac during CSF - 1 - induced cytoskeletal remodeling and spreading in osteoclasts [ J]. Bone ,2006,6 : 1290 - 1301.
  • 10谢小伟,康鹏德,裴福兴,谭钢.破骨细胞在激素性股骨头坏死发展中的作用[J].中华骨科杂志,2012,32(7):698-701. 被引量：7

二级参考文献75

  • 1李子荣,张鹤山（整理）,李子荣（整理）.股骨头坏死诊断与治疗的专家建议[J].中华骨科杂志,2007,27(2):146-148. 被引量：284
  • 2Wang Y, Li Y, Mao K, et al. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis [ J ]. Clin Orthop Relat Res,2003,213 - 224.
  • 3Suh KT, Kim SW, Roh HL, et al. Decreased osteogenic differentiation of mesenchymalstem cells in alcohol-induced osteonecrosis [ J ]. Clin Orthop Relat Res,2005,220 - 225.
  • 4Wang Y,Yin L,Li Y,et al. Preventive effects of puerarin on alcohol- induced osteonecrosis [J]. Clin Orthop Relat Res, 2008,466 : 1059 - 1067.
  • 5Yeh CH,Chang JK,Wang YH,et al. Ethanol may suppress wnt/β - catenin signaling on human bone marrow stroma cells [J]. Clinical Orthopaedics and Related Research ,2008,466 : 1047 - 1053.
  • 6Glueck CJ,Freiberg RA,Oghene J,et al. Association between the T- 786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur[J]. J Bone Joint Surg(Am) ,2007,89:2460 -2468.
  • 7Kyung Hoi Koo, JSLYJLK JKJJYHJK. Endothelial nitrie oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis[J]. 2006,1722 - 1728.
  • 8Kim TH, Hong JM,Lee JY,et al. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population [ J ]. Osteoarthritis Cartilage ,2008,16:287 - 291.
  • 9Bjorkman A,Svensson PJ, Hillarp A,et al. Factor V leiden and prothrombin genemutation: risk factors for osteonecrosis of the femoral head in adults [ J ]. Clin Orthop Relat Res,2004,168 - 172.
  • 10Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment[ J]. J Bone Joint Surg(Br) , 1985,3 - 9.

共引文献73

同被引文献47

  • 1赵万军,肖鲁伟,周辉,韩勇,童培建,吴承亮.激素性股骨头坏死中医病机学实验研究[J].中国中医骨伤科杂志,2005,13(2):23-27. 被引量：27
  • 2臧银善,刘晓华,张缪佳.系统性红斑狼疮并发骨坏死的相关因素分析[J].中国医刊,2007,42(1):46-49. 被引量：10
  • 3Boyanov M,Robeva R,Popivanov P.Bone mineral density changes in women with systemic lupus erythematosus[J].Clin Rheumatol,2003,22(4/5):318-323.
  • 4Mok CC,Mak A,Ma KM.Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus[J].Lupus,2005,14(2):106-112.
  • 5Steinbuch M,Youket TE,Cohen S.Oral glucocorticoid use is associated with an increased risk of fracture[J].Osteoporos Int,2004,15(4):323-328.
  • 6Suzuki Y,Sato S.Secondary osteoporosis UPDATE.Clinical significance glucocorticoid-induced osteporosis[J].Clin Calcium,2010,20(5):645-653.
  • 7Ruiz-Irastorza G,Danza A,Khamashta M.Glucocorticoid use and abuse in SLE[J].Rheumatology(Oxford),2012,51(7):1145-1153.
  • 8Pereira RM,Carvalho JF,Canalis E.Glucocorticoid-induced osteoporosis in rheumatic diseases[J].Clinics(Sao Paulo),2010,65(11):1197-1205.
  • 9Coimbra IB,Costallat LT.Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset,plasmatic estradiol and immunosupressive therapy[J].Joint Bone Spine,2003,70(1):40-45.
  • 10Uaratanawong S,Deesomchoke U,Lertmaharit S,et al.Bone mineral density-4-in premenopausal women with systemic lupus erythematosis[J].J Rheumatol,2003,30(11):2365-2368.

引证文献3

二级引证文献13

中国矫形外科杂志
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部